STAT3 and neoplasm: In tumor-bearing mice, STAT3 inhibition resulted in MDSC depletion in spleens, but not tumors [87], leading to the notion that the signaling pathways governing these cells and their differential downstream effects are critical in their immunosuppressive capacity.